1
|
Cross K, Harding K. Risk profiling in the prevention and treatment of chronic wounds using artificial intelligence. Int Wound J 2022; 19:1283-1285. [PMID: 36131590 PMCID: PMC9493230 DOI: 10.1111/iwj.13952] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/24/2022] [Indexed: 12/13/2022] Open
|
2
|
Moore ZEH, Aynge GE, Carr CG, Horton AJ, Jones HA, Murphy NS, Payne MR, McCarthy CH, Murdoch JM. A Clinical Support App for routine wound management: reducing practice variation, improving clinician confidence and increasing formulary compliance. Int Wound J 2022; 19:1263-1275. [PMID: 35793908 PMCID: PMC9284651 DOI: 10.1111/iwj.13868] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2022] [Revised: 05/18/2022] [Accepted: 05/29/2022] [Indexed: 11/27/2022] Open
Abstract
Wounds continue to be of a global concern. Therefore, a more focussed, evidence-based approach to wound assessment and management is required. The WOUND COMPASS™ Clinical Support App (CSA) is designed to support the health care professional with wound assessment and management at the point of care. This real-world pilot study aimed to determine the utility of the CSA during routine wound management, in multiple care settings. A non-interventional, real-world pilot programme of the CSA was conducted at four sites. Patients received routine wound management. The CSA was programmed to replicate the site's formulary for evidence-based wound management. Anonymised pre- and post-pilot clinician opinion surveys on useability and impact of the CSA were collected and reported. Wound Specialists (n = 7 [100%]) and Non-Wound Specialists (NWS) (n = 58 [82%]) indicated that competence and confidence in wound assessment were enhanced with use of the CSA (100%; 82%). Furthermore, practice variation was reduced because of a greater compliance to their local formulary (n = 7 [100%]; 79% [54%]). This real-world pilot shows the positive impact of the CSA, and the improvements that can be potentially realised via reduction in practice variation, improvement in NWSs confidence when managing wounds and increased formulary compliance.
Collapse
Affiliation(s)
- Zena E H Moore
- Skin Wounds and Trauma (SWaT) Research Centre, School of Nursing and Midwifery, RCSI University of Medicine and Health Services, Dublin, Ireland.,School of Nursing & Midwifery, Griffith University, Gold Coast, Queensland, Australia.,School of Health Sciences, Faculty of Life and Health Sciences, Ulster University, Ulster, UK.,School of Medicine, Cardiff University, Cardiff, UK.,Department of Nursing, Fakeeh College for Medical Sciences, Jeddah, Saudi Arabia.,Faculty of Medicine and Health Sciences, UGent, Ghent University, Ghent, Belgium.,School of Nursing and Health, Lida Institute, Shanghai, China
| | - Georgina E Aynge
- Tissue Viability, Medway NHS Foundation Trust, Medway Maritime Hospital, Gillingham, UK
| | - Caryn G Carr
- Tissue Viability, Southern Health NHS Foundation Trust, Long Term Conditions Centre, Lyndhurst, UK
| | - Aundrea J Horton
- Education, Home Health and Hospice HCA, Nashville, Tennessee, USA
| | - Hayley A Jones
- Tissue Viability, Medway NHS Foundation Trust, Medway Maritime Hospital, Gillingham, UK
| | - Nina S Murphy
- Interim Operational Lead for Long Term Condition, Northeast London Foundation Trust, Mayflower Community Hospital, Blunts, UK
| | - Matthew R Payne
- Tissue Viability, Southern Health NHS Foundation Trust, Long Term Conditions Centre, Lyndhurst, UK
| | - Catherine H McCarthy
- Global Clinical Strategy - Advanced Wound Management, Smith and Nephew, Watford, UK
| | - Julie M Murdoch
- Global Clinical Strategy - Advanced Wound Management, Smith and Nephew, Watford, UK
| |
Collapse
|